ProteinSimple Maurice Parts & Components

Closed Solicitation Posted

Solicitation number
75F40124Q00325
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Silver Spring, Maryland, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Office of Product Quality and Research (OPQR) is issuing a Request for Quotation (RFQ) to obtain replacement parts and components for its ProteinSimple CE-SDS/cIEF (Maurice) protein characterization and analysis system. The solicitation is using simplified acquisition procedures on an unrestricted basis, and the Government will award a firm-fixed-price purchase order to the lowest priced, technically acceptable offeror. The required products include various CE-SDS and cIEF cartridges, buffers, reagents, standards, and other consumables needed to operate and maintain the Maurice instrument. Quotes are due by June 11, 2024 and must be submitted by email.

This procurement has no set-aside designation. The Maurice instrument is currently owned and operated by the FDA OPQR. The Government is seeking brand-name only parts and components from Bio-Techne ProteinSimple to maintain operation of the instrument. Delivery must occur in September 2024 and will take place in Silver Spring, MD.

Notice text

Please see attachment titled 'Sol_RFQ Attachment_75F40124Q00325'.

Files

Similar open opportunities

Opportunity Agency Set-aside Responses due
Combined Synopsis Solicitation- Acquire Preventati NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors